Related Experiment Video
Updated: Sep 17, 2025

Isolation of Macrophage Subsets and Stromal Cells from Human and Mouse Myocardial Specimens
Published on: December 17, 2019
A macrophage gene-regulatory network linked to clinical severity of coronary artery disease : The STARNET and
Lijiang Ma1,2, Jacqueline E Tamis-Holland3, Giuseppe Mocci4
1Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Insights
Coronary artery disease (CAD) is a major global health issue. This study identified a macrophage gene regulatory network (GRNGREEN) causally linked to CAD severity, offering potential therapeutic targets like NEIL1.
Area of Science:
- Genetics and Systems Biology
- Cardiovascular Disease Research
- Immunology and Macrophage Biology
Background:
- Coronary artery disease (CAD) is a leading cause of mortality worldwide.
- Macrophages are key players in the pathogenesis of CAD.
- Understanding macrophage gene regulatory networks (GRNs) is crucial for CAD research.
Purpose of the Study:
- To explore and validate the role of macrophage GRNs in clinically significant CAD.
- To identify key driver genes within these networks associated with CAD severity.
- To assess the heritability contribution and therapeutic potential of identified GRNs.
Main Methods:
- Integrative systems genetics analysis of primary blood macrophage RNA sequencing (RNAseq) data from STARNET and NGS-PREDICT studies.
- Inference of macrophage GRNs, differential gene expression analysis, and identification of key driver genes.
- Analysis of expression quantitative traits (eQTLs), genome-wide association studies (GWAS), and retrospective/prospective validation in independent datasets.
Main Results:
- Identified 23 macrophage GRNs, with GRNGREEN significantly associated with CAD severity (SYNTAX score).
- GRNGREEN comprises 729 genes, 90 key drivers (top: NEIL1), accounts for 3.73% of CAD heritability, and contains 34 known CAD GWAS genes.
- GRNGREEN involves SRP-dependent co-translational protein targeting to the membrane and was validated in multiple independent datasets.
Conclusions:
- GRNGREEN is causally associated with CAD severity and contributes significantly to CAD heritability.
- NEIL1 is identified as a top key driver gene within GRNGREEN.
- GRNGREEN and NEIL1 represent potential therapeutic targets for preventing and treating CAD by modulating macrophage function.
Abstract:
Coronary artery disease (CAD) is a major cause of global morbidity and mortality. Macrophages play a central role in orchestrating this disease process. In 2016, we initiated the STARNET primary blood macrophage study, followed by the multi-ethnic NGS-PREDICT primary blood macrophage study in 2018. We applied integrative systems genetics analysis to explore and validate the role of macrophage gene regulatory co-expression networks (GRNs) in clinically significant CAD. This study included 318 CAD cases and 134 CAD-free controls in STARNET, and 95 CAD cases and 35 CAD-free controls in NGS-PREDICT. Primary leukocytes were isolated from blood and differentiated into macrophages in vitro, followed by RNA extraction and deep sequencing (RNAseq). In STARNET, we analyzed differentially expressed genes, inferred macrophage GRNs, assessed the phenotypic associations and functions of these GRNs, and determined their key driver genes. Integrative analysis of STARNET expression quantitative traits (eQTLs) with genotype data from genome-wide association studies was performed to determine the content of CAD candidate genes in these GRNs, and their contributions to CAD heritability. Five independent RNAseq datasets were used to retrospectively validate CAD-associated macrophage GRNs, followed by prospective validation in the NGS-PREDICT study. Using the STARNET datasets, we identified 23 macrophage GRNs. Of these, GRNGREEN stood out as being causally associated with CAD severity (SYNTAX score) and comprised 729 genes and 90 key drivers, with the top key driver being NEIL1. GRNGREEN accounted for 3.73% of CAD heritability and contained 34 candidate genes previously identified by GWAS of CAD. Functional analysis of GRNGREEN revealed a large portion of genes involved in the biological process of SRP-dependent co-translational protein targeting to the membrane. GRNGREEN replicated retrospectively in five independent human arterial wall RNAseq datasets, and prospectively in the NGS-PREDICT study. To prevent clinically significant CAD, GRNGREEN and its top key driver NEIL1 may be suitable therapeutic targets to modify SRP-dependent co-translational targeting of proteins to the endoplasmic reticulum in macrophages.
More Related Videos
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome III: Diagnostic Studies
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...